Obstetrics & gynaecology

Elagolix reduces menstrual bleeding from most common uterine tumors

A new oral drug significantly reduced menstrual bleeding for women with the most common gynecologic tumors in the United States—benign tumors that disproportionately affect African-Americans, an international clinical trial ...

Oncology & Cancer

Breast cancer risk in African-Americans tied to genetic variations

Two gene variants found in African American women may explain why they are more likely to be diagnosed with triple negative breast cancer (TNBC) than white women of European ancestry, according to Weill Cornell Medicine and ...

page 7 from 22